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Summary
The Bordetella type III secretion system (T3SS)
effector protein BteA is necessary and sufficient
for rapid cytotoxicity in a wide range of mammalian
cells. We show that BteA is highly conserved and
functionally interchangeable between Bordetella
bronchiseptica, Bordetella pertussis and Borde-
tella parapertussis. The identiﬁcation of BteA
sequences required for cytotoxicity allowed the
construction of non-cytotoxic mutants for localiza-
tion studies. BteAderivatives were targeted to lipid
rafts and showed clear colocalization with cortical
actin, ezrin and the lipid raft marker GM1. We
hypothesized that BteA associates with the cyto-
plasmic face of lipid rafts to locally modulate host
cell responses to Bordetella attachment. B. bron-
chiseptica adhered to host cells almost exclusively
to GM1-enriched lipid raft microdomains and BteA
colocalized to these same sites following T3SS-
mediated translocation. Disruption of lipid rafts
with methyl-b-cyclodextrin protected cells from
T3SS-induced cytotoxicity. Localization to lipid
rafts was mediated by a 130-amino-acid lipid raft
targeting domain at the N-terminus of BteA, and
homologous domains were identiﬁed in virulence
factors from other bacterial species. Lipid raft tar-
geting sequences from a T3SS effector (Plu4750)
and an RTX-type toxin (Plu3217) from Photor-
habdus luminescens directed fusion proteins to
lipid rafts in a manner identical to the N-terminus of
BteA.
Introduction
Lipid membrane rafts (rafts), which are prominent targets
for bacterial, viral and protozoan pathogens (Manes et al.,
2003; Lafont et al., 2004; Riff et al., 2005; Mejia et al.,
2008), are specialized membrane microdomains enriched
in cholesterol and sphingolipids that produce ordered
structures distinct from surrounding areas of disordered,
predominantly unsaturated lipid species (Simons and
Ikonen, 1997, Laude and Prior, 2004). The clustering of
signalling proteins and lipid cofactors within rafts sug-
gests they function as platforms where close proximity
increases efficiency and speciﬁcity of signalling cascades
(Hanzal-Bayer and Hancock, 2007, Viola and Gupta,
2007). Although controversy exists regarding the size,
function and precise physical nature of rafts (Edidin, 2003;
Munro, 2003; Laude and Prior, 2004; Skwarek, 2004),
considerable evidence supports their importance for
attachment of bacterial pathogens (e.g. Mycoplasma, Shi-
gella, enteropathogenic Escherichia coli, Porphyromonas,
Yersinia) (Lafont et al., 2004; Riff et al., 2005; Allen-
Vercoe et al., 2006; Hawkes and Mak, 2006, Mejia et al.,
2008; Hayward et al., 2009), bacterial invasion (Shigella,
Salmonella, Listeria, Mycobacterium, Chlamydia) (Manes
et al., 2003; Lafont et al., 2004; Lafont and van der Goot,
2005a), oligomerization of pore-forming toxins (aerolysin,
streptolysin O, listeriolysin O) (Gekara et al., 2005) and
cell-surface binding by A-B toxins (cholera toxin, shiga
toxin) (Takenouchi et al., 2004; Lencer and Saslowsky,
2005). Recent evidence suggests that association of
Salmonella and Shigella type III secretion system (T3SS)
translocon components with target cell membranes is
cholesterol-dependent (Lafont and van der Goot, 2005b).
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cellular microbiologyAlthough interactions between bacterial components and
the exofacial surface of lipid rafts have been extensively
studied, virulence factor targeting events occurring on the
cytoplasmic side of rafts are less well understood.
In this study we report an analysis of the activity and
intracellular localization of BteA, a 658 amino acid (aa)
effector protein secreted by the Bordetella bsc T3SS
(Panina et al., 2005; Kuwae et al., 2006). The bsc T3SS is
most extensively characterized in Bordetella bronchisep-
tica, the broad-host-range evolutionary progenitor of Bor-
detella pertussis and Bordetella parapertussis that cause
acute respiratory diseases in humans (Yuk et al., 1998;
2000). Although nearly identical T3SS loci are encoded in
the genomes of all three species, the ability to readily
detect T3SS activity in vitro, and the availability of natural-
host animal models to study respiratory infection have
made B. bronchiseptica the species of choice for studying
typeIIIsecretionbyBordetella.ThelociencodingbteAand
thebscT3SSapparatusareco-regulatedbythealternative
sigmafactorBtrS,whichinturnisdependentontheBvgAS
phosphorelay for expression (Mattoo et al., 2004). In addi-
tion to transcriptional control, the partner-switching pro-
teins BtrU, BtrV and BtrW regulate secretion through a
complex series of protein–protein interactions, serine-
phosphorylation and serine-dephosphorylation events
(Mattoo et al., 2004; Kozak et al., 2005). BteA is an un-
usually potent cytotoxin capable of inducing rapid, non-
apoptoticdeathinadiversearrayofcelltypes,andprecise,
multilevel control of expression and secretion may be
essential for its role in promoting persistent colonization of
the respiratory epithelium (Stockbauer et al., 2003; Panina
et al., 2005; Shrivastava and Miller, 2009). BteAis the only
Bordetella effector that has been identiﬁed and its central
importance is illustrated by the observation that null muta-
tions in bteA recapitulate phenotypes associated with
mutations that eliminate type III secretion altogether
(Panina et al., 2005). Despite its central role in patho-
genesis, little is known regarding the events that occur
following BteA injection into target cells. In the course of
analysing the intracellular localization of BteA, we have
identiﬁedalipidrafttargeting(LRT)motiffoundinvirulence
determinants expressed by diverse bacterial pathogens.
Results
BteA is functionally conserved among Bordetella
species
The bsc T3SS loci encoded by B. pertussis, B. paraper-
tussis and B. bronchiseptica are highly conserved (Yuk
et al., 1998). bteA and btcA, which encode the BteAeffec-
tor and its chaperone, respectively, are present in the
genomes of all three species and are predicted to encode
nearly identical proteins (Fig. 1A). As shown in Fig. 1B,
bteA alleles from B. pertussis and B. parapertussis were
able to complement a DbteA derivative of B. bronchisep-
tica strain RB50. Cytotoxicity against rat lung epithelial
(L2), human epithelial (HeLa) and mouse lung epithelial
(MLE12) cells was restored to levels comparable to those
observed with the RB50 bteA allele, and the morphologi-
cal characteristics of dying cells were identical (data not
shown). The slightly lower levels of complementation
observed with B. parapertussis BteA correspond to its
greater degree of divergence. These results demonstrate
that the BteA effector proteins encoded by Bordetella
species are functionally conserved.
Identiﬁcation of non-cytotoxic BteA derivatives
A characteristic of the wild-type BteA protein is the induc-
tion of rapid, non-apoptotic cytotoxicity in a wide range of
target cells (Stockbauer et al., 2003; Panina et al., 2005).
In an attempt to identify a time interval where BteA might
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Fig. 1. B. pertussis, B. parapertussis and B. bronchiseptica bteA
alleles are functionally interchangeable.
A. Schematic representation of bteA loci from three Bordetella
species. The per cent amino acid identities between
B. bronchiseptica proteins and their homologues in human-adapted
B. pertussis and B. parapertussis are indicated. Positions of
residues that differ between B. bronchiseptica and other species
are shown by vertical bars.
B. B. pertussis and B. parapertussis bteA alleles are functionally
interchangeable with B. bronchiseptica bteA. HeLa, L2 and MLE-12
epithelial cell lines were infected with wild-type B. bronchiseptica
RB50 (WT), a DbteA derivative (DbteA), the DbteA strain
complemented with vector alone (pvec), or the DbteA strain
complemented with bteA loci from B. bronchiseptica RB50
(pbteABb), B. pertussis Tohama 1 (pbteABp), or B. parapertussis
12822 (pbteABpp). Cytotoxicity was measured by LDH release
assays performed 1 h post infection at a multiplicity of infection of
50:1.
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© 2009 Blackwell Publishing Ltd, Cellular Microbiology, 11, 1735–1749be detected and localized prior to the onset of cell death,
we performed the time-course experiment shown in
Fig. 2A. bteA was inserted downstream from the CMV
promoter in plasmid pEGFP-N1, fusing EGFP to the
C-terminus of BteA. Expression of the resulting fusion
construct, BteA658-EGFP, was analysed by ﬂuorescence
microscopy at time intervals beginning 2 h after transfec-
tion. With the vector control, GFP-positive cells could be
identiﬁed as early as 4 h., while no GFP-positive cells
were found at any time point following transfection with
the construct encoding BteA658-EGFP (Fig. 2B), and the
fusion protein was not detectable by Western blot analysis
(data not shown). Lactate dehydrogenase (LDH) release
assays showed that expression of BteA with the
C-terminal EGFP tag resulted in a level of cytotoxicity
comparable to the native untagged protein (Fig. 2B).
These data show that even trace amounts of BteA658-
EGFP expression are sufficient to induce cytotoxicity and
prevent detection of the fusion protein by ﬂuorescence
microscopy or Western blot analysis.
We reasoned that BteA derivatives with reduced cyto-
toxicity would be required for localization studies to
proceed. A series of bteA fragments truncated at their 3′
termini were cloned into pEGFP-N1 to create C-terminal
fusions with EGFP (Fig. 2B). Following transfection into
HeLa cells, expression of BteA–EGFP derivatives was
monitored by ﬂuorescence microscopy and cytotoxicity
was measured by LDH release assays (Fig. 2B).Although
BteA652-EGFP retained full cytotoxicity, further truncations
eliminated activity. The markedly reduced LDH release
following transfection with BteA644-EGFP indicates that
the last 14 aa of BteA are critical for full cytotoxicity. To
determine if the BteA644 mutant retains structural features
of the wild-type protein, we assessed its ability to self-
associate, a characteristic of native BteA (Panina et al.,
2005). Full-length BteAresolves as high-molecular-weight
multimers on SDS-PAGE (Fig. 2C), a property that corre-
lates with the formation of ﬁbres in buffered aqueous
solution that can be visualized by electron microscopy
(data not shown). BteA644 retains this ability to form SDS-
insoluble high-molecular-weight species, suggesting that
it maintains its core structural scaffold despite a signiﬁcant
loss of cytotoxicity.
BteA644 localizes to ezrin- and GM1-rich membrane sites
We next examined the localization of BteA644-EGFP in
HeLa and L2 cells by scanning confocal microscopy. As
shown in Fig. 3A, BteA644-EGFP clearly colocalized with
cortical actin. BteA was observed to associate with
regions of the cell surface (Fig. 3A, arrowheads), but not
actin stress ﬁbres, suggesting that it targets proteins
and/or lipids positioned in the vicinity of actin-associated
membrane sites. Cortical actin participates in the forma-
tion of signalling platforms with membrane receptor
cytoplasmic domains (Xavier et al., 2004; Gajate and
Mollinedo, 2005; Halayko and Stelmack, 2005; Chichili
and Rodgers, 2009). These signalling complexes are
often located at lipid raft microdomains anchored to the
actin cytoskeleton by members of the ERM (ezrin-radixin-
moesin) family of adaptor proteins. (Bretscher et al.,
2002; Hoeﬂich and Ikura, 2004). We were thus interested
to determine whether BteAcolocalizes with ezrin, an ERM
protein prominently expressed by HeLa cells. Cells trans-
fected with constructs expressing BteA644-EGFP or EGFP
alone were stained using antibodies against ezrin. Con-
focal microscopy revealed a high degree of colocalization
between BteA644-EGFP and ezrin, but not EGFP and
ezrin, suggesting that BteA is speciﬁcally targeted to
ezrin-enriched membrane sites (Fig. 3B and C).
In many cells examined, BteA644-EGFP was particularly
prominentinﬁlopodia.Filopodiaarerod-likeprojectionson
the cell surface that are supported by cortical actin and
function in sampling and exploration of the environment
(Fig. 3B) (Bryant, 1999; Small et al., 2002; Faix et al.,
2009). BteA644 expression appeared to increase both the
number and length of these structures in HeLa cells
(Fig. 3B).Incontrast,EGFPalone(Fig. 3C)didnotlocalize
to ﬁlopodia and did not result in abnormal ﬁlopodia forma-
tion. Due to their sensory and exploratory function, ﬁlopo-
dia possess a large number of transmembrane receptors
and raft-associated signalling complexes, which vary
according to cell type and growth conditions (Lidke et al.,
2005; Ladwein and Rottner, 2008). As ﬁlopodia usually
containhighconcentrationsoflipidrafts,wenextexamined
the colocalization of BteA with GM1 ganglioside, which
serves as a marker for lipid rafts. Cells expressing BteA644-
EGFP were stained using ﬂuorescently labelled cholera
toxin subunit B (CtxB), which binds with high avidity and
speciﬁcity to ganglioside GM1 (Schon and Freire, 1989).
Nearly complete colocalization was observed between
BteA644-EGFP and GM1 (Fig. 3D). High-magniﬁcation XZ
scans of the region indicated by the arrowhead in Fig. 3D
further demonstrate that transfected BteA localizes pre-
cisely with GM1 in cell membranes (Fig. 3E).
BteA contains a conserved, multifunctional N-terminal
domain
The BteA proteins expressed by Bordetella species are
highly homologous, especially within an N-terminal
130 aa segment (Fig. 1A). Using iterative PSI-BLAST, six
homologues of this domain were found in Photorhabdus
luminescens and two others in Vibrio splendidus and Pho-
torhabdus asymbiotica (Fig. 4Aand B). We had previously
predicted that two of the P. luminescens proteins (Plu0822
and Plu4750) function as T3SS effectors on the basis of
their close proximity to class I chaperones (Panina et al.,
Lipid-raft targeting by Bordetella effector BteA 1737
© 2009 Blackwell Publishing Ltd, Cellular Microbiology, 11, 1735–1749Fig. 2. BteA is a potent cytotoxin for mammalian cells.
A. Full-length BteA is not detected in eukaryotic cells by ﬂuorescence microscopy. HeLa cells were transfected with BteA
658-EGFP or EGFP
alone for 2, 4, 6 or 21 h and visualized via ﬂuorescence microscopy. Typical images of the same ﬁeld showing green ﬂuorescence and DAPI
nuclear staining are shown.
B. Full-length BteA (aa 1–658) and C-terminally truncated mutants were fused to EGFP (green bars) on the plasmid pEGFP-N1. The EGFP
tag is not drawn to scale. The N-terminal BteA domain (aa 1–130) is shown in red and residues at EGFP fusion junctions are indicated.
Constructs were transfected into HeLa cells and cytotoxicity was measured 21 h later by LDH release assays. Cytotoxicity measurements are
expressed relative to untagged, wild-type BteA.
C. Western blot analysis of complex formation by full-length BteA
658-FLAG (658 aa) and the non-cytoxic derivative BteA
644-FLAG (644 aa)
using a-FLAG monoclonal antibody. Both proteins were expressed in a DbteA derivative of B. bronchiseptica strain RB50. RB50 expressing
untagged full-length BteA was used as a negative control. High-molecular-weight complexes (arrowheads) were observed for both
BteA
658-FLAG and BteA
644-FLAG in whole-cell extracts and culture supernatants. Images shown are representative of three independent
experiments.
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© 2009 Blackwell Publishing Ltd, Cellular Microbiology, 11, 1735–17492005). The remaining four P. luminescens proteins
(Plu1341, Plu1344, Plu3217, Plu3324) and the proteins
from V. splendidus and P. asymbiotica are homologous to
RtxA, an atypical RTX toxin with actin cross-linking activity
(Lin et al., 1999; Fullner and Mekalanos, 2000).
Given the presence of homologous sequences in known
and putative virulence determinants from multiple species,
we hypothesized that the N-terminal 130 aa segment of
BteA may perform a conserved cellular function, possibly
by directing localization. This was tested by fusing the ﬁrst
130 aa of BteA to EGFP (BteA130-EGFP) and examining
transfected cells by confocal microscopy. BteA130-EGFP
localized to GM1-positive lipid rafts in a manner indistin-
guishable from BteA644-EGFP (Figs 3D and 5B respec-
tively). Similarly, the localization patterns of all C-terminal
truncated derivatives of BteA (Fig. 3B) were indistinguish-
able from BteA644-EGFP, while the ﬁrst 30 aa of BteA was
unabletodirectEGFPtomembranesites(datanotshown).
When a construct lacking the N-terminal 130 aa region of
BteA(BteA131-644-EGFP) was tested, it too failed to localize
to GM1-stained raft microdomains (Fig. 5C). These obser-
vations demonstrate that an LRT signal of BteA is con-
tained between aa 1 and 130.Although the BteALRTmotif
is essential for localization, it is not required for cytotoxicity
following transfection (Fig. 5D). Expression of BteA131-658-
EGFP conferred a high level of cytotoxicity, even though
there was no detectable localization to the cell membrane.
Although overexpression of toxic domains may compen-
sate for the lack of localization following transfection,
membrane association is likely to be important during
T3SS-mediated translocation (see Discussion).
N-terminal sequences of T3SS effectors contain secre-
tion signals and often mediate chaperone–effector inter-
actions (Harrington et al., 2003). bteA is directly adjacent
to a divergently transcribed locus, btcA, which is predicted
to encode a class I chaperone (Panina et al., 2005). As
shown in Fig. 5E, full-length BteA associates with BtcA in
a bacterial two-hybrid system (Dove and Hochschild,
2004) and the 130 aa LRT domain is both necessary and
sufficient for this interaction. Taken together, our results
show that the N-terminus of BteA is multifunctional, medi-
ating chaperone interactions and directing the localization
of BteA to lipid raft microdomains in eukaryotic cells.
BteA fractionates with detergent-resistant membranes
The relative insolubility of cholesterol in Triton X-100 facili-
tates the separation of cholesterol-enriched lipid rafts
during cell fractionation (Ignoul et al., 2007). Detergent-
resistant membrane (DRM) fractions were prepared from
Fig. 3. BteA localization. BteA
644-EGFP was transfected into HeLa cells. Eighteen hours later cells were ﬁxed, permeabilized and visualized by
laser scanning confocal microscopy. Images represent average composite Z-stacks processed by Leica’s LCS software. BteA
644-EGFP
colocalization was assessed using Alexa Fluor 568-conjugated phalloidin to stain actin (A), Alexa Fluor 633 a-ezrin (B and C) and Alexa Fluor
555-labelled CtxB to stain GM1 ganglioside (D).
E. XZ scans of the region indicated by the arrow in (D). Colocalization appears as yellow for two-colour overlays, or white in three-colour
overlay (4D), and is representative of a single Y section.
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© 2009 Blackwell Publishing Ltd, Cellular Microbiology, 11, 1735–1749HeLa cells transfected with BteA–EGFP derivatives to
further investigate the association between BteA and lipid
rafts.HeLacellsexpressingEGFP,BteA644-EGFP,BteA130-
EGFP or BteA130-644-EGFP were fractionated by Triton
X-100 solubilization followed by sucrose gradient density
centrifugation. Cellular fractions were separated by SDS-
PAGE and Western blots were probed with antibody to
EGFP.As expected, fusion constructs containing the BteA
LRT domain (BteA644- and BteA130-EGFP) were abundant
in the low-density Triton X-100-insoluble DRM fractions,
suggesting that BteA associates with rafts, raft proteins or
associated protein complexes (Fig. 6). Notably, the distri-
bution pattern of BteAin DRMs was nearly identical to that
of ezrin and the lipid raft marker, caveolin-1. Although
clearly associated with lipid rafts, the presence of detect-
able levels of LRT-containing BteA derivatives, ezrin and
caveolin in dense cellular fractions is likely due to the
presence of non-membrane-associated intracellular pools
and/or disruption of complexes during fractionation. In
contrast, BteA130-644-EGFP and the EGFP-negative control
were exclusively present in dense, non-membrane-
associated Triton X-100-soluble fractions. Thus, the LRT
domain-dependentfractionationofBteAwithinDRMscoin-
cides with results from colocalization studies.
BteA is translocated to the cytoplasmic face of
membrane raft locations that function as sites for
bacterial attachment
The observation that BteA targets discrete locations on
host cell membranes prompted us to examine whether a
correlation exists with sites of Bordetella attachment.
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Fig. 4. Distribution of LRT domains in putative bacterial virulence factors.
A. Schematic representation of known and predicted proteins with LRT domains (red bars) and their closest homologues lacking LRT
sequences. The schematic is not drawn to scale. Homologous domains are coloured as indicated. The cysteine protease domain in RtxA and
related toxins, and a cleavage site identiﬁed in RtxA, are indicated by hatched boxes and an arrow respectively (Sheahan et al., 2007) (see
Discussion). Species origin is indicated in parentheses by a two-letter code: Bb, B. bronchiseptica; Bp, B. pertussis; Bpp, B. parapertussis;
Pl, P. luminescens; Pa, Photorhabdus asymbiotica, Vs, V. splendidus.
B. Alignment of LRT domains in known and predicted virulence factors. The central region of the BteA LRT domain (aa 34–112) is shown, with
identical amino acids present in all nine sequences in red and conserved residues in blue.
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© 2009 Blackwell Publishing Ltd, Cellular Microbiology, 11, 1735–1749HeLa cells were infected with wild-type B. bronchiseptica
strain RB50 for 15 min, a time point before cytotoxicity is
observed. Cells were washed to remove unbound bacte-
ria, ﬁxed and stained with CtxB. Remarkably, almost every
cell-associated bacterium was found to colocalize with
GM1-positive rafts (Fig. 7A). We reasoned that B. bron-
chiseptica may speciﬁcally adhere to lipid rafts and that
BteA functions locally following injection, or that BteA
and/or other T3SS-associated factors actively recruit
GM1-rich structures to sites of Bordetella attachment. To
distinguish these possibilities we analysed the attachment
pattern of a T3SS ATPase mutant, RB50 DbscN (Yuk
et al., 1998), which adhered to GM1-enriched sites in a
manner indistinguishable from wild-type RB50 (Fig. 7B).
Association with lipid rafts therefore is independent of
T3SS activity and is likely mediated by adhesin speciﬁcity.
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Fig. 5. The N-terminal LRT domain of BteA mediates chaperone binding and host cell localization.
A. Constructs used in this experiment. Notations are the same as in Fig. 3A. HeLa cells were transfected with BteA
130-EGFP (B) or
BteA
130-644-EGFP (C). EGFP fusion proteins and Alexa Fluor 555-labelled CtxB bound to GM1 were visualized by confocal microscopy. Images
are single Z sections. Colocalization between transfected proteins and GM1 appears as yellow on the overlay images.
D. Cytotoxicity assays. Full-length (BteA
658) or truncated BteA–EGFP fusion constructs were transfected into HeLa cells and LDH release was
measured 21 h post transfection. Cytotoxicity is expressed as a percentage relative to wild-type BteA.
E. Bacterial two-hybrid analysis of interactions between BtcA, BteA and BteA domains. The pTRG target vector alone (vec), or pTRG
expressing full-length BtcA fused to the amino-terminal domain of the alpha subunit of RNA polymerase was transformed with the pBT bait
vector (vec), or pBT expressing full-length BteA (BteA
658), or fragments truncated at their N- and/or C-termini fused to the C-terminus of the
lambda repressor.
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© 2009 Blackwell Publishing Ltd, Cellular Microbiology, 11, 1735–1749We next determined if BteA localizes to lipid rafts
following T3SS-mediated translocation by adherent
Bordetella. HeLa cells were infected with RB50 deriva-
tives expressing haemagglutinin (HA)-tagged BteA
(BteA644-HA), permeabilized with Triton X-100 and stained
with DAPI, CtxB and an a-HA monoclonal antibody.
BteA644-HA closely associated with adherent bacteria
(Fig. 8A) and colocalized with GM1-positive lipid rafts
(Fig. 8B). XZ confocal scans of the region marked in
Fig. 8B (arrow) show that BteA is translocated into lipid
rafts that coincide with sites of bacterial attachment
(arrowheads, Fig. 8C). T3SS-translocated BteA644-HA
could not be visualized when the Triton X-100 membrane
permeabilization step was omitted, indicating that BteA
was not localized to the outer surface of the plasma mem-
brane (data not shown). Deletions in loci encoding the
BscN ATPase (RB50 DbscN), or the BopB translocon
component (RB50 DbopB), eliminated the ability to detect
raft-associated BteA644-HA, demonstrating a requirement
for T3SS-mediated translocation (data not shown). These
data demonstrate that translocated BteA associates with
the cytoplasmic face of lipid rafts that serve as attachment
sites for Bordetella, and suggest that BteA acts locally
following bacterial attachment. It is interesting to note
that only a subset of adherent bacteria are associated
with translocated BteA at any given time (Fig. 8A). The
mechanistic basis for this lack of synchrony is currently
unknown.
Disruption of lipid rafts decreases T3SS-induced
cytotoxicity
As both B. bronchiseptica and BteA preferentially localize
to lipid rafts, we were curious to determine if the integrity
of cholesterol-enriched membrane domains is impor-
tant for attachment and/or T3SS-mediated cytotoxicity.
Methyl-b-cyclodextrin (MBCD), a cyclic glucose oligomer
that forms soluble inclusion complexes with cholesterol,
was used to disrupt lipid rafts (Shaw, 2006). HeLa cells
were pretreated with 2.5 mM MBCD or media alone for
30 min, washed and brieﬂy infected with B. bronchisep-
tica RB50. Mild treatment conditions were employed to
minimize the MBCD-dependent cytotoxicity observed with
higher concentrations or longer exposure. As shown in
Fig. 9A, a modest decrease in bacterial attachment was
observed at 20 min, a time before T3SS-induced cytotoxi-
city could be detected. In the experiment in Fig. 9B, HeLa
cells were ﬁrst infected with B. bronchiseptica RB50 for
Fig. 6. BteA is present in DRM fractions from transfected cells.
HeLa cells were transfected with the constructs indicated (left
sidebar), and fractionated as described in Experimental procedures.
Western blots were probed with a-EGFP or antibodies to ezrin and
caveolin as indicated in the left sidebar. Transfected (T) or
untransfected (U) cell controls are shown in the right sidebar.
Lanes within the red outline are low-density DRM fractions.
Fig. 7. B. bronchiseptica RB50 adheres to
GM1-containing lipid rafts. Images are
single Z sections, and are representative of
at least three separate experiments. HeLa
cell monolayers were infected with
B. bronchiseptica strain RB50 (A) or the
T3SS-defective strain RB50 DbscN (B) for
25 min, washed, ﬁxed and stained. DAPI
staining (green) reveals bacteria adherent to
HeLa cells. GM1 appears red, and overlap is
yellow in the merged images.
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media alone. In this case, no signiﬁcant difference was
observed between MBCD-treated cells and untreated
controls, indicating that treatment with MBCD has little
effect on previously attached Bordetella.
Having identiﬁed a MBCD treatment protocol that was
non-toxic and did not disrupt bacterial attachment, we next
determined the effects of cholesterol depletion on T3SS-
inducedcytotoxicity.HeLacellswereinfectedwithB. bron-
chiseptica RB50 for 15 min, treated with MBCD or media
alonefor30 min,washedextensivelyandtheinfectionwas
allowed to proceed for a total of 2 h. As shown in Fig. 9C,
cytotoxicity was reduced to background levels in cells
subjected to mild treatment with MBCD. These results
suggest that BteA-mediated cytotoxicity following Borde-
tella infection is dependent on the integrity of lipid rafts.
Functional conservation of LRT domains in T3SS
effectors and RTX toxins
The relative positions of LRT domains differ according to
the known or predicted nature of the protein; T3SS effec-
tors bear them near their N-termini while RTX-type toxins
encode them near the middle of their 3500- to 4900-aa-
long sequences (Fig. 4A). Having demonstrated that the
BteA LRT domain is necessary and sufficient for mem-
brane localization, we determined whether putative LRT
sequences from two P. luminescens ORFs, one predicted
to encode a T3SS effector (Plu4750) and the other an
RTX toxin (Plu3217), were capable of directing EGFP
fusion constructs to lipid rafts. Sequences encoding the
P. luminescens LRT domains were fused to EGFP at their
C-termini and transfected into HeLa cells. As predicted,
both LRT sequences localized the EGFP fusion con-
structs to ezrin-rich sites, despite their presence in other-
wise unrelated proteins (Fig. 10A–C). Moreover, the same
localization pattern was observed when full-length
Plu4750 was fused to EGFP, conﬁrming that the LRT motif
functions as predicted in the context of the entire protein
(Fig. 10C). On the basis of these observations we con-
clude that the N-terminal LRT motif of BteA deﬁnes a
newly identiﬁed family of localization domains that target
diverse bacterial proteins to membrane rafts in eukaryotic
cells.
Fig. 8. BteA is translocated by the bsc T3SS into lipid rafts that coincide with sites of bacterial attachment. A single HeLa cell is shown,
infected with RB50 expressing an HA-tagged BteA
644 (BteA
644-HA) and stained using DAPI (bacteria) and antibody to HA.
A. BteA
644-HA (red) colocalizes with adherent bacteria (green).
B. 100¥ magniﬁcation, XY confocal image of BteA
644-HA stained with DAPI for bacteria (blue), a-HA (red) and GM1 ganglioside (green).
C. 100¥ magniﬁcation XZ scan and merged images of the same portion of the cell as in (B). The arrows indicate the position of bacterial cells.
Colocalization appears yellow in two colour overlays, and white in triple colour overlays.
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BteA is the only Bordetella T3SS effector protein
described to date (Panina et al., 2005). This stands in
marked contrast to other T3SS-expressing species where
numerous effectors have been identiﬁed by proteomic,
bioinformatic or translocation screens (Fouts et al., 2002;
Chang et al., 2005). BteA is both necessary and sufficient
for the induction of rapid cell death in a remarkably broad
range of cell types (Panina et al., 2005). Although BteA
has no full-length homologues among previously charac-
terized proteins, it is highly conserved and functionally
interchangeable between Bordetella species. Despite its
central role in virulence, the molecular function and intra-
cellular targets of BteA have remained elusive.
The potent cytotoxicity of BteA precludes the ability to
detect even trace amounts of full-length protein in mam-
malian cells. A deletion of 14 aa from the C-terminus was
sufficient to eliminate cytotoxicity. This derivative, BteA644,
retained the ability to form high-molecular-weight,
detergent-insoluble complexes that were similar to full-
length BteA, suggesting that the structural scaffold of the
protein remains intact. Most importantly, the reduction of
cytotoxicity permitted the efficient detection of intracellular
protein. Following transfection or T3SS-mediated translo-
cation, BteA644 clearly localized to ezrin- and GM1-rich
membrane microdomains in HeLa cells as observed by
confocal microscopy. Localization was dependent on the
130 aa LRT motif present at the N-terminus of BteA.
Identical patterns of localization were observed with BteA
derivatives that retain the LRT sequence, and its removal
disrupted normal targeting. As predicted, BteA associated
with low-density, detergent-insoluble membrane fractions
from transfected cells, indicating direct or indirect asso-
ciation with lipid rafts. Importantly, BteA displayed a
pattern of localization following T3SS-mediated transloca-
tion that was identical to that observed following transfec-
tion. When sites of Bordetella attachment were examined,
nearly every cell-associated bacterium was found to colo-
calize with GM1 and there was a striking correlation
between the position of extracellular bacteria and the
location of translocated BteA. These observations tempt
the hypothesis that BteA modulates localized cellular
responses to Bordetella infection, and we speculate that
this may be especially relevant to interactions with phago-
cytic antigen-presenting cells. This is consistent with pre-
vious results showing T3SS-dependent modulation of T
cell- and B cell-mediated responses during B. bronchisep-
tica infections (Skinner et al., 2005; Pilione and Harvill,
2006; Siciliano et al., 2006).
Although lipid raft localization is likely to be essential
under physiologically relevant conditions, a BteA130-658
construct lacking LRT sequences displayed cytotoxic
activity following transfection. This contrasts with obser-
Fig. 9. MBCD treatment interferes with bacterial attachment and
protects cells from T3SS-mediated cytotoxicity.
A. HeLa cells incubated with media alone (black bars) or 2.5 mM
MBCD (grey bars) for 30 min were washed and infected with
wild-type B. bronchiseptica RB50 for 15 min at a multiplicity of
infection of 50:1. Following infection, cells were extensively
washed, solubilized and adherent bacteria measured as colony
forming units (cfu) per well. All statistical analyses were performed
using the Student’s t-test with data from three independent
experiments. Asterisk indicates a P-value < 0.001.
B. HeLa cells were ﬁrst infected with wild-type B. bronchiseptica
RB50 for 15 min, washed and incubated with media alone (black
bars) or 2.5 mM MBCD (grey bars) for 30 min Cells were
extensively washed, solubilized, and adherent bacteria measured
as cfu per well. There was no statistically signiﬁcant difference
between untreated and MCDB-treated cells.
C. HeLa cells infected with B. bronchiseptica RB50 for 15 min,
or uninfected, were incubated with media alone (black bars) or
2.5 mM MBCD (striped bars) for 30 min as described in (B). Cells
were then washed and incubated in fresh media for 2 h. Bars
indicate cytotoxicity measured by LDH release as a percentage of
maximum cell lysis. Wells designated as ‘Max lysis’ were treated
with MBCD as described above and lysed with 0.9% Triton-X100 to
generate maximum values for LDH release.
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an otherwise identical manner and that depletion of mem-
brane cholesterol with MBCD abrogates BteA-dependent
cell death following T3SS-mediated delivery. A likely
explanation is that the LRT domain plays an essential role
in facilitating interactions between BteA and host cell
targets during T3SS-mediated translocation, and overex-
pression of BteA following transfection eliminates the
need for LRT-dependent localization. In addition to its role
in membrane association, the BteA LRT domain also con-
tains sequences that mediate secretion and chaperone
binding. The identiﬁcation of mutations that disrupt target-
ing without affecting secretion or translocation will facili-
tate further studies on the importance of LRT for BteA
function. Experiments aimed at identifying BteA binding
partners responsible for localization and/or cytotoxicity
are also underway. On the basis of results presented
here, we expect that BteA targets will be associated with
the host cell membrane and cholesterol-rich domains.
Likely candidates include components of membrane-
associated signalling complexes that are found in lipid
rafts and are known to be associated with the cortical
actin cytoskeleton.
The BteA LRT domain represents a newly identiﬁed
motif capable of directing proteins to lipid rafts. Although
the identiﬁcation of similar sequences at the N-termini of
other T3SS effectors was not unexpected, we were
intrigued to ﬁnd homologous motifs in RTX-type toxins. A
model has been recently proposed for Vibrio cholerae
RtxA, which postulates that both N-terminal and
C-terminal sequences associate with the plasma mem-
brane and mediate translocation of the central portion of
the protein into the cytosol. A cysteine protease domain
then cleaves the toxin between L3428 and A3429
(Fig. 4A) and additional cleavage events liberate the actin
cross-linking and Rho-inactivation domains from their
membrane anchors (Sheahan et al., 2007; Prochazkova
and Satchell, 2008). As homologous cysteine protease
domains are found in all of the RTX-type toxins shown in
Fig. 4A, proteolytic processing following cytosolic delivery
is likely to be a common feature (Sheahan et al., 2007).
For the P. luminescens and V. splendidus RTX-type
toxins, we propose that adjacent LRT motifs target activity
domains released by proteolysis to GM1-rich lipid rafts.
The relative positions of cleavage sites would determine
exactly which domains colocalize with the LRT. Although
Fig. 10. Functional conservation of LRT
domains from T3SS effectors and RTX-type
toxins. Colocalization of ezrin with the isolated
LRT domains from Plu3217 (A) and Plu4750
(B) fused to EGFP, and with the full-length
Plu4750 protein fused to EGFP (C). HeLa
cells were transfected with expression
plasmids for EGFP fusion proteins, stained for
GM1 and visualized by confocal microscopy.
Colocalization between transfected proteins
and GM1 appears as yellow on the merged
images. Images are single Z sections.
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lence determinants with completely different translocation
mechanisms, the ability of the LRT domains from a Pho-
torhabdus effector and an RTX-type toxin to guide fusion
proteins to lipid rafts clearly demonstrates conserved
function.
Photorhabdus luminescens is a bacterial symbiont of
entomopathogenic nematodes. It is transported to the
hemocoel of an insect prey, which is then killed by an
arsenal of toxins and T3SS effectors (Derzelle et al.,
2004). V. splendidus is a dominant Vibrio in coastal sedi-
ments and seawater, which is pathogenic for bivalves and
ﬁsh and shares an ecological niche with V. cholerae
(Lacoste et al. 2001, Gay et al., 2004). B. bronchiseptica
infects the respiratory epithelia of a wide range of
mammals, including humans, and appears to have an
environmental reservoir as well (Akerley et al., 1995). The
evolutionary journey the LRT domain has taken between
pathogens of insects, ﬁsh and mammals provides a
poignant example of the conservation of virulence
mechanisms in nature and exempliﬁes the ancient origins
of bacterial–host interactions.
Experimental procedures
Bacterial strains and cell culture
HeLa cells were maintained in DMEM (Gibco) supplemented with
10% Fetal Bovine Serum (FBS, Hyclone) and penicillin-
streptomycin. L2 cells were maintained in DMEM or F12K media
(Invitrogen) supplemented with 10% FBS and pen-strep. Both cell
linesweregrownat37°Cina5%CO2atmosphere.B. bronchisep-
tica strains RB50, RB50 DbscN, DbteA and DbopB have been
previously described (Cotter and Miller, 1994; Yuk et al., 1998;
Panina et al., 2005). Full-length or truncated bteA loci from
B. bronchiseptica, B. pertussis Tohama I or B. parapertussis
strain 12822 (Parkhill et al., 2003) were cloned into pBBR1MCS-5
for expression in Bordetella.A l lB. bronchiseptica-derived strains
were cultured in Stainer-Scholte liquid medium or on Bordet-
Gengou agar medium (Becton Dickinson Microbiology Systems,
San Jose, CA) containing 7.5% deﬁbrinated sheep blood (Mission
Laboratories, Rosemead, CA) and appropriate antibiotics for
plasmid selection.
Construction of BteA–EGFP and LRT-EGFP fusions
Genes encoding full-length BteA (BteA658) and BteA derivatives
with C-terminal deletions (BteA30, BteA300, BteA400, BteA500,
BteA540, BteA580, BteA620, BteA628, BteA644 and BteA652) were
cloned into the NheI and HindIII restriction sites in pEGFP-N1
(Clontech), in-frame with the C-terminal EGFP tag. bteA frag-
ments were PCR-ampliﬁed from B. bronchiseptica RB50 using
Herculase (Stratagene). All fragments include the ﬁrst codon of
BteA and terminate at the codon indicated by their superscript
designation (e.g. BteA
300 includes codons 1–300). EGFP-tagged
mutants containing N-terminal BteA deletions (BteA
131-644,
BteA
131-658) were constructed by cloning BteA fragments into the
same sites on pEGFP-N1 and addingATG start codons for trans-
lation initiation. LRT domains from Plu4750 (codons 1–132),
Plu3217 (codons 1808–1907) and the full-length Plu4750 protein
(codons 1–316) were cloned from P. luminescens sp. lumine-
scens (ATCC) into pEGFP-N1 to construct EGFP fusions. An
N-terminal ATG codon was added immediately upstream of LRT
sequences from Plu3217.
Cytotoxicity assays, transfection and MBCD treatments
Bordetella bronchiseptica strains expressing or bteABb, bteABp or
bteABpp alleles grown to mid-log phase were added to cell cul-
tures at a multiplicity of infection of 50:1 and centrifuged onto
cultured cells at 640 g for 5 min. DMEM + 1% FBS was added to
cells following a thorough wash with PBS, and incubated at 37°C
for indicated periods of time. Cytotoxicity was assayed with the
CytoTox 96 LDH release assay kit (Promega) (Lappalainen et al.,
1994) following the manufacturer’s suggested procedures. To
analyse cytotoxicity from transfected constructs, HeLa or L2 cells
grown in 12-well plates were transfected with 1.6 mg of plasmid
DNA using Lipofectamine LTX (Invitrogen). Transfected cell cul-
tures were brieﬂy centrifuged to remove cell debris, and 50 mlo f
media was removed and assayed for LDH release at various
times post transfection. For MBCD protection or attachment
assays, HeLa cells were washed with PBS and incubated in
DMEM + 2.5 mM MBCD (Sigma Aldrich) for 30 min. MBCD-
containing medium was removed, cells were washed with PBS
and cultured in reduced serum DMEM (1.0% FBS) lacking
MBCD. Fifteen minutes after centrifugation, colony-forming units
of attached bacteria were assayed by spreading serial dilutions of
the cell lysate on BG agar medium following washing and solu-
bilization of the cell monolayer in 0.2% Triton X-100. Bordetella-
induced cytotoxicity was measured as described above at 2 h
post infection.
Confocal microscopy
Cells were grown in multiwell plates on glass coverslips and
transfected as described above. Eighteen hours post transfec-
tion, cells were washed and ﬁxed with 4% paraformaldehyde in
1¥ PBS for 30 min at room temperature. To visualize EGFP
fusion proteins, glass slides were mounted using Vectashield
mounting media (Vector Laboratories) and sealed with clear nail
polish. For actin and ezrin staining, cells were permeabilized with
0.1% Triton X-100 for 10 min, and stained with either Alexa
Fluor-conjugated phalloidin (Invitrogen) or a-ezrin primary anti-
body (BD Biosciences) followed by ﬂuorescently labelled second-
ary antibody (Invitrogen). GM1 staining using Alexa Fluor 555-
labelled CtxB was performed as described (Chen et al., 2007).
HeLa cells infected with B. bronchiseptica were washed twice
with PBS, ﬁxed as described above, and B. bronchiseptica was
visualized using Vectashield mounting media with DAPI (Vector
Laboratories). All images were acquired with a Leica SP2-AOBS
laser scanning confocal microscope set-up. Images shown in the
ﬁgures are representative of at least three independent experi-
ments and were produced with Leica’s LCS confocal software.
Western blot analysis
Bordetella bronchiseptica strains were grown overnight in
Stainer-Scholte medium and cell cultures were separated into
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pared by dissolving pellets in Laemmli buffer (Laemmli, 1970).
Proteins from supernatant fractions were precipitated with 10%
trichloroacetic acid for 6 h at 4°C. OD equivalents of B. bron-
chiseptica whole-cell lysates and supernatants were separated
on 10% SDS-PAGE gels and transferred to PVDF membranes
(Millipore). Membranes were incubated with mouse a-FLAG anti-
body (Sigma Aldrich) and antigen–antibody complexes were
detected with horseradish peroxidase-conjugated a-mouse
immunoglobulin (Amersham Biosciences) and visualized by
chemiluminescence using SuperSignal West Pico chemilumines-
cent substrate (Pierce, Rockford, IL).
Bacterial two-hybrid analysis
Bordetella bronchiseptica sequences were cloned into the
BacterioMatch (Stratagene) two-hybrid ‘bait’ vector pBT, creat-
ing fusions with the C terminus of the lambda cI protein, and/or
into the cognate ‘target’ vector pTRG, creating fusions with the
amino-terminal domain of the alpha subunit of RNA polymerase.
Clones were conﬁrmed by sequence analysis and cotrans-
formed into the BacterioMatch I reporter strain (XL1Blue MRF′
laqI
q bla lacZ Kan
r). To assay b-galactosidase activity, overnight
cultures were subcultured to an optical density (OD600)o f0 . 0 7i n
LB medium containing tetracycline (15 mgm l -1) and chloram-
phenicol (34 mgm l
-1). Cultures were incubated at 30°C until the
OD600 reached 0.4, at which point isopropyl b-D-thiogalactoside
was added to a ﬁnal concentration of 10 mM. After 2 h of iso-
propyl b-D-thiogalactoside induction, cells were harvested and
permeabilized with SDS and CHCl3, and b-galactosidase activity
was measured using the method described by Miller (Sommer
et al., 1978).
DRM fractionation
The DRM fractions were prepared from HeLa cells as described
(Ignoul et al., 2007). Approximately 18 h after transfection with
BteA- and LRT-fusion derivates, 1–2 ¥ 10
7 cells were washed
with PBS, scraped into 1 ml of lysis buffer containing 1.0% Triton
X-100 and protease inhibitor cocktail (Roche), and adjusted to a
ﬁnal sucrose concentration of 45%. The cell lysate was overlaid
with a 30–5% sucrose step gradient, and separated for 16 h at
38 000 r.p.m. by isopycnic ﬂoatation in a Beckman SW-41 rotor.
1 ml fractions were collected and sedimented in a Ti70.1 rotor at
40 000 r.p.m. for 1 h. The pellets were resuspended in 1¥
Laemmli buffer (Laemmli, 1970) and electrophoresed on 4–16%
gradient SDS-PAGE gels (Bio-Rad). Proteins were transferred to
PVDF-Plus membranes (Amersham) and probed with rabbit
a-EGFP (Abcam), mouse a-ezrin (BD-Biosciences) or mouse
a-caveolin-1 (Santa Cruz). Chemiluminescent detection was
performed using Amersham’s ECL reagents and Kodak BioMax
MS ﬁlm.
Bacterial attachment assays
HeLa cells pre-incubated with MBCD or media alone as
described above were infected with B. bronchiseptica RB50 at a
multiplicity of infection of 50:1 for 25 min. Infected cultures were
brieﬂy centrifuged at 640 g for 5 min followed by a thorough wash
with PBS. Cells were solubilized in 0.2% Triton X-100, and ali-
quots assayed for colony-forming units on BG agar medium. In
parallel, attached B. bronchiseptica were stained, visualized by
light microscopy, and manually counted.
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